BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 25, 2012
View Archived Issues
Phase II VTX-2337 trial in persistent ovarian cancer begins
Read More
Roche reviews highlights of third quarter 2012
Read More
Phase III MM-003 study meets primary endpoint
Read More
Study finds genetic variants associated with response to cocaine vaccine
Read More
Calcium-activated potassium channel expression investigated in Parkinson's disease model
Read More
Novel antibacterial thiolactomycin analogues presented
Read More
Chinese researchers disclose new agents for cancer
Read More
Bayer Schering Pharma prepares novel TTK inhibitors
Read More
New c-Cot inhibitors patented by Glenmark Pharmaceuticals
Read More
Researchers at Amgen patent novel protein kinase inhibitors
Read More
Duke University presents novel oligopeptides for inflammation and neurological conditions
Read More
Urine MIF could be a useful biomarker of interstitial cystitis
Read More
Astex Pharmaceuticals begins phase II study of its HSP 90 inhibitor
Read More
Seattle Genetics and Abbott expand antibody-drug conjugate collaboration
Read More
FDA accepts NDA filing for ponatinib
Read More
4SC Discovery receives research grant to develop personalized cancer drugs
Read More
Agenus begins phase II study of HerpV vaccine
Read More
Compound-loaded artificial bone acts on host cells to induce regeneration
Read More
Phase III trial of ALK-Abello's allergy vaccine meets primary endpoint
Read More
Investigator-sponsored trial of Cytori's cell therapy for scleroderma cleared in France
Read More
Xalkori granted conditional approval in Europe
Read More
Ataluren benefits selected patients with cystic fibrosis in phase III trial
Read More
EMA accepts for review lurasidone MAA
Read More
Phase III trial of reparixin in pancreatic islet transplantation enrolls first patient
Read More
Oryzon receives grant from Spanish government to develop LSD1 inhibitors for acute leukemia
Read More